Find Clinical Trials
The efficacy and safety of trimetazidine in patients with angina pectoris having been treated by percutaneous coronary intervention ATPCI study. An international, multicentre, randomised, double-blind, placebo-controlled study in patients treated for 2 to 4 years.
Servier Protocol Code:
CL3-06790-010
Sponsor:
Institut de Recherches Internationales Servier (I.R.I.S)
EudraCT Number:
2010-022134-89
Other protocol name:
PER-084-13
Find a recruiting site
Name:
Institut de Recherches Internationales Servier, Département des études cliniques
Phone number:
+33 1 55 72 60 00
Results
English (USA)Interventions / Treatments
The treatment(s) given to the participants in the study.
- Coronary Artery Disease
- S006790
- TRIMETAZIDINE
Other study id numbers
Other identification numbers the study may be known by.
- CL3-06790-010